Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: A case control pilot study

European Heart Journal

Volumn 29, Issue 2, 2008, Pages 185-190

  Hinterseer, Martin ^a   Thomsen, Morten B ^b   Beckmann, Britt Maria ^a   Pfeufer, Arne ^c,d   Schimpf, Rainer ^e   Wichmann, H Erich ^c   Steinbeck, Gerhard ^a   Vos, Marc A ^b   Kaab, Stefan ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Beat to beat Variability of repolarization Proarrhythmia; Drug induced Long QT Syndrome; Torsades de Pointes

Indexed keywords

AMIODARONE; CIPROFLOXACIN; CITALOPRAM; CLOFAZIMINE; HALOPERIDOL; IMIPRAMINE; MOXIFLOXACIN; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ2; RIZATRIPTAN; SODIUM CHANNEL; SOTALOL; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL 5;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; GENE MUTATION; GENOTYPE; HEART BEAT; HUMAN; HYPERTENSION; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION;

AGED; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; TORSADES DE POINTES;

EID: 38349141919     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm586     Document Type: Article

References (30)

1. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-1022.
2. Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998;97:2237-2244.
3. Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 2006;259:39-47.
4. Sanguinetti MC, Tristani-Firouzi M. HERG potassium channels and cardiac arrhythmia. Nature 2006;440:463-469.
5. Marban E. Cardiac channelopathies. Nature 2002;415:213-218.
6. Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res 2000;47:219-233.
7. Thomsen MB, Matz J, Volders PGA, Vos MA. Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias. Pharmacol Ther 2006;112:150-170.
8. Roden DM. Taking the 'idio' out of 'idiosyncratic': predicting torsades de pointes. Pacing Clin Electrophysiol 1998;21:1029-1034.
9. Nguyen PT, Scheinman MM, Seger J. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval. Circulation 1986;74:340-349.
10. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994;121:529-535.
11. Hondeghem LM, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 2001;103:2004-2013.
12. Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, Van Opstal JM, Volders PG, Vos MA. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation 2004;110:2453-2459.
13. Gbadebo TD, Trimble RW, Khoo MS, Temple J, Roden DM, Anderson ME. Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes. Circulation 2002;105:770-774.
14. Kaab S, Hinterseer M, Nabauer M, Steinbeck G. Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome - a case-control pilot study using i. v. sotalol. Eur Heart J 2003;24:649-657.
15. Thomsen MB, Volders PG, Beekman JD, Matz J, Vos MA. Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol 2006;48:1268-1276.
16. Thomsen MB, Oros A, Schoenmakers M, van Opstal JM, Maas JN, Beekman JDM, Vos MA. Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. Cardiovasc Res 2007;73:521-530.
17. Thomsen MB, Truin M, van Opstal JM, Beekman JD, Volders PG, Stengl M, Vos MA. Sudden cardiac death in dogs with remodeled hearts is associated with larger beat-to-beat variability of repolarization. Basic Res Cardiol 2005;100:279-287.
18. Pfeufer A, Jalilzadeh S, Perz S, Mueller JC, Hinterseer M, Illig T, Akyol M, Huth C, Schopfer-Wendels A, Kuch B, Steinbeck G, Holle R, Nabauer M, Wichmann HE, Meitinger T, Kaab S. Common Variants in Myocardial Ion Channel Genes Modify the QT Interval in the General Population. Results From the KORA Study. Circ Res 2005;96:693-701.
19. Holle R, Happich M, Loewel H, Wichmann HE. KORA - a research platform for population based health research. Gesundheitswesen 2005;1925.
20. Wichmann HE, Gieger C, Illig T. KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005;26-30.
21. Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952;6:378-388.
22. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-370.
23. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-1565.
24. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994;330:235-241.
25. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori SG, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT. Spectrum of mutations in Long-QT syndrome genes KvLQT1, HERG, SCN5A, KCNE1 and KCNE2. Circulation 2000;102:1178-1185.
26. Schwartz PJ, Malliani A. Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 1975;89:45-50.
27. Antoons G, Stengl M, Thomsen MB, Beekman J, Vos M, Sipido K. Sarcoplasmic reticulum Ca2+ release and repolarization lability in myocytes from the dog with chronic atrioventricular block (cAVB). (Abstract). Biophys J 2005;88:298A.
28. Wu L, Shryock JC, Song Y, Belardinelli L. An Increase in Late Sodium Current Potentiates the Proarrhythmic Activities of Low-Risk QT-Prolonging Drugs in Female Rabbit Hearts. J Pharmacol Exp Ther 2006;316:718-726.
29. van Opstal JM, Schoienmakers M, Verduyn SC, de Groot SH, Leunissen JD, Der Hulst FF, Molenschot MM, Wellens HJ, Vos MA. Chronic Amiodarone evokes no Torsade de Pointes arrythmias despite QT lengthening in an animal model of acquired long QT syndrome. Circulation 2001;104:2722-2727.
30. Hinterseer M, Irlbeck M, Ney L, Beckmann BM, Pfeufer A, Steinbeck G, Kaab S. Acute respiratory distress syndrome with transiently impaired LV function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman. Br J Anaesth 2006;97:150-153.